Navigation Links
Comment of Senator Patrick Leahy (D-Vt.) on President-elect Obama's Choice of Former Senator Tom Daschle to Head The Department of Health and Human Services and A New White House Office of Health Reform
Date:12/11/2008

WASHINGTON, Dec. 11 /PRNewswire-USNewswire/ -- President-elect Obama has made another superb choice in selecting Tom Daschle to head the Department of Health and Human Services as well as a new White House Office of Health Reform. Tom Daschle is a born leader and a skilled policymaker, and he has been a friend for 25 years.

Health care reform is sorely needed and long overdue. It will be one of the core projects of the Obama presidency and certainly one of the most complex and difficult issues on the nation's agenda. No one is better prepared for this monumental job than Tom Daschle is. His talents, his experience, his vision and his decency are admired on both sides of the aisle. I look forward to working with him to help make health reform a reality.


'/>"/>
SOURCE Office of U.S. Senator Patrick Leahy
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. AANMA Provides Commentary to FDA Advisory Committees Reviewing Benefit-Risk Assessment of 12 Hour Bronchodilators
2. American College of Surgeons Comments on Institute of Medicine Report on Resident Duty Hours
3. Assurant Comments on A.M. Best Ratings Statement; Ratings Continue to Reflect Assurants Solid Financial Position
4. Consumer Watchdog Comments on Health Insurers Self-Serving Support of Individual Mandate
5. Analyst Available to Comment on New JUPITER Study That Shows AstraZenecas Crestor Significantly Reduces CV Risk
6. The Senior Citizens Leagues Comments on U.S. Supreme Court Case Wyeth v. Levine
7. Seyfarth Shaw Partner Camille A. Olson, Senate Witness for ADA Amendments Act, Comments on President's Signing of Bill into Law
8. Conscience Protections Essential to Healthcare System, Americans United for Life Argues in Comments Filed with HHS
9. Duska Therapeutics Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis
10. Endocare Comments on Unsolicited Proposal
11. Susan G. Komen for the Cure(R) Comments on Christina Applegates Breast Cancer Diagnosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2017)... ... June 25, 2017 , ... FCPX LUT Vintage Volume ... old-fashioned vintage look. FCPX LUT Vintage Volume 2 contains 60 different color-grade presets, giving ... distorted looks, vignettes and blurs to single out subjects, plus much more. FCPX LUT ...
(Date:6/25/2017)... ... , ... With a heatwave currently bearing down on Northern California pushing temperatures to the maximum, ... ready is easy with laser hair removal. , The process of summer waxing and ... when all you want to do is get out, dive in and cool off. There ...
(Date:6/24/2017)... ... June 24, 2017 , ... The weather is heating ... outdoors. Home and business owners should be aware that the summer months provide more ... fact, mechanical locks and keys can be negatively affected from direct exposure to the ...
(Date:6/23/2017)... ... June 23, 2017 , ... Yesterday, U.S. Senate Republicans ... to repeal and replace the Affordable Care Act (ACA). Like the bill narrowly ... to Medicaid, a public health insurance program for low-income children, pregnant women, parents ...
(Date:6/23/2017)... ... 23, 2017 , ... Everybody has their own personal preference when it comes ... and some people don't like it at all. FindaTopDoc took a look at what ... literature can give readers a taste of their deepest, darkest fantasies and has the ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... ALTO, Calif. , June 9, 2017 ... device company focused on the design, manufacture, sale and ... the market on the progress of its commercial roll-out ... is now available in more than one hundred (100) ... AeroForm offers a needle-free alternative for ...
(Date:6/7/2017)... 7, 2017 Endo International plc (NASDAQ: ... the Hon. Joseph R. Goodwin , U.S. District ... West Virginia , entered a case management order ... System Products Liability Litigation (the "MDL") that includes a ... provide expert disclosures on specific causation within one hundred ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly and ... that results from the Phase 3 MONARCH 2 ... & 6 inhibitor, in combination with fulvestrant, significantly ... fulvestrant alone in women with hormone-receptor-positive (HR+), human ... cancer who have relapsed or progressed after endocrine ...
Breaking Medicine Technology: